Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL)

NCT00174785 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00174785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL)
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2005
Completion date
March 31, 2008
Enrollment
4,628 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial flutter